Health Innovation Research


Headache Study

If so, you could help test a new product in a medical study to investigate headache pain treatment.

Please note that this study is by remote participation – no in-clinic visits required. 

Check your eligibility here

Read our COVID-19 Summary Here

If you experience 2 or more headaches per month, you could help with this research.

Thank you for your interest in RDC Clinical’s new study, into the effectiveness of a natural product previously researched for its anti-inflammatory and pain-relieving properties. To help with this study, we’re looking for males and females 18 years and older who currently experience 2 or more headaches per month.

Simply record up to 5 headaches over the 4-month study period. 

So that we can scientifically measure the product’s effectiveness, you would be required to record your headache pain and take the study product up to 5 times over a 4-month period.

If you’d like to take part in this study, we’d love your help. More information is below, the eligibility & registration form is on this page.

About the product you’ll help test…

The product is PEA, which is a fatty acid that occurs naturally in the body. It has been widely studied for its anti-inflammatory and pain-relieving properties. 

The aim of this study is to access the effectiveness of PEA compared to ibuprofen for reducing the pain severity and duration of headaches. As this study compares the two products, you will have an equal (50%) chance of being allocated either PEA or ibuprofen.

About the study you’ll take part in… headache monitoring.

Once enrolled in the trial, you’ll be provided with the study product in capsule form.

The maximum study duration for each participant is 4 months. During that time, you will be required to record data for up to 5 headache episodes.

For each head episode you will be required to:

  • Take 3 capsules of the study product upon headache onset.
  • Score your headache pain severity every 30 minutes for a maximum of 4 hours.

You will be permitted to also use your normal pain medication after the first hour if required.

If you’re a headache sufferer and would like to take part, please register your interest by answering the questionnaire and completing the form on this page… we’ll then get in touch to screen you for suitability.

This study can be completed remotely as all requirements can be completed by phone and online. There is no requirement for participants to visit our clinic site.

Check if you can take part… study participant requirements.

Are you…

  • A male or female aged 18 years and older?
  • Currently experiencing 2 or more headaches per month?
  • A non-smoker?
  • Generally healthy?
  • Do NOT have a sensitivity to ibuprofen?
Ethics approval & privacy… you’ll be in safe, professional hands.

This RDC Clinical study has been approved by the Bellberry Human Research Ethics Committee under Approval Number: 2017-05-397-A-3. The study is also registered on the Australian and New Zealand Clinical Trial Registry under Registration Number: ACTRN12618000294257.

Trained Trial Co-ordinators will supervise your progress throughout the study. Your results in the study will be made fully available to you. Any of your personal information collected during the study will be kept in the strictest confidence and your rights as a participant are fully reserved and no identifying information is ever published.

You can complete the study at home, there are no in-clinic visits required

This study requires that you log your headache pain severity at the time of your headache. As such, there is no requirement for in-clinic visits. Simply fill in the online form via a link that will be provided to you after your enrolment. 

COVID-19 Update Summary

Due to the current situation surrounding COVID-19 we have implemented a number of strategies to assist our valued participants and trial coordinators.

As part of our response, we are implementing either reduced or contactless visits where possible. If you have any concerns about attending an appointment, please let us know when we call you for screening and we can discuss what options are available for your study. 

RDC is located in a small business centre with car parking available directly at our door. We are not located in or near a hospital or medical precinct, or in an area where large numbers of people congregate. As a small clinic, we have a maximum of 3 participants at any one time attending our site, and there is adequate space in both the waiting and interview areas for social distancing. All appointments are one-on-one with a trial coordinator; no group appointments are conducted. 

Share This